1611 - 1620 of 8620 Results
Title
Year
-
OPENTitle: Secondary Worsening Following DYT1 Dystonia Deep Brain Stimulation: A Multi-country CohortJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.00242Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.00242/pdfCitation Count: 16
-
OPENTitle: STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.578615Best OA location URL: https://doi.org/10.3389/fnhum.2020.578615Citation Count: 38
- Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson’s Disease2020OPENTitle: Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.602595Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.602595/pdfCitation Count: 3
- Cognitive Outcomes for Essential Tremor Patients Selected for Thalamic Deep Brain Stimulation Surgery Through Interdisciplinary Evaluations2020OPENTitle: Cognitive Outcomes for Essential Tremor Patients Selected for Thalamic Deep Brain Stimulation Surgery Through Interdisciplinary EvaluationsJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.578348Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.578348/pdfCitation Count: 7
- The UF Deep Brain Stimulation Cognitive Rating Scale (DBS-CRS): Clinical Decision Making, Validity, and Outcomes2020OPENTitle: The UF Deep Brain Stimulation Cognitive Rating Scale (DBS-CRS): Clinical Decision Making, Validity, and OutcomesJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.578216Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.578216/pdfCitation Count: 6
-
OPENTitle: Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial CellsJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2020.00033Best OA location URL: https://doi.org/10.3389/fimmu.2020.00033Citation Count: 67
- Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson Disease2020OPENTitle: Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson DiseaseJournal Name: World NeurosurgeryPublisher: Elsevier BVVol: 139Issue #:Start Page: e784End Page: e791Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.wneu.2020.04.160Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S187887502030869XCitation Count: 2
- The Nrf2-mediated defense mechanism associated with HFE genotype limits vulnerability to oxidative stress-induced toxicity2020OPENTitle: The Nrf2-mediated defense mechanism associated with HFE genotype limits vulnerability to oxidative stress-induced toxicityJournal Name: ToxicologyPublisher: Elsevier BVVol: 441Issue #:Start Page: 152525End Page: 152525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2020.152525Best OA location URL: https://scholarsphere.psu.edu/resources/0165b409-31f0-464c-9424-715ab3ca7de4Citation Count: 13
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 109
- Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys2020OPENTitle: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeysJournal Name: eBioMedicinePublisher: Elsevier BVVol: 59Issue #:Start Page: 102944End Page: 102944Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944Best OA location URL: http://www.thelancet.com/article/S2352396420303200/pdfCitation Count: 63